Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution
Authors:
- Niels J. BrouwerNiels J. Brouwer
- Gülçin GezginGülçin Gezgin
- Annemijn P.A. WierengaAnnemijn P.A. Wierenga
- Inge H.G. BronkhorstInge H.G. Bronkhorst
- Marina MarinkovicMarina Marinkovic
- Gregorius P.M. LuytenGregorius P.M. Luyten
- Mieke VersluisMieke Versluis
- Wilma G.M. KroesWilma G.M. Kroes
- Pieter A. van der VeldenPieter A. van der Velden
- Robert M. VerdijkRobert M. Verdijk
- Martine J. JagerMartine J. Jager
Open Access
Abstract
Increased angiogenesis is associated with a higher metastasis- and mortality rate in uveal melanoma (UM). Recently, it was demonstrated that genetic events, such as 8q-gain and BAP1-loss, influence the level of immune infiltrate. We aimed to determine whether genetic events, and specific cytokines, relate to angiogenesis in UM. Data from UM patients who underwent enucleation between 1999 and 2008 were analysed. Microvascular density (MVD) and the presence of infiltrating immune cells were determined with immunohistochemistry (IHC) and immunofluorescence in 43 cases. Chromosome status, BAP1 IHC and mRNA expression of angiogenesis-related genes were known in 54 cases. Tumours with monosomy 3/BAP1-loss showed a higher MVD compared to tumours with disomy 3/normal BAP1 expression (p = 0.008 and p = 0.004, respectively). Within BAP1-positive lesions (n = 20), 8q-gain did not relate to MVD (p = 0.51). A high MVD was associated with an increased expression of angiopoietin 2 (ANGPT2) (p = 0.041), Von Willebrand Factor (VWF) (p = 0.010), a decreased expression of vascular endothelial growth factor B (VEGF-B) (p = 0.024), and increased numbers of tumour-infiltrating macrophages (CD68+, p = 0.017; CD68+CD163+, p = 0.031) and lymphocytes (CD4+, p = 0.027). Concluding, vascular density of UM relates to its genetic profile: Monosomy 3 and BAP1-loss are associated with an increased MVD, while an early event (gain of 8q) is not independently related to MVD, but may initiate a preparation phase towards development of vessels. Interestingly, VEGF-B expression is decreased in UM with a high MVD.Keywords
Funding Information
- Algemene Nederlandse Vereniging ter voorkoming van Blindheid (N.A.)
- Stichting Blinden-Penning (N.A.)
- Landelijke Stichting voor Blinden en Slechtzienden (N.A.)
- Novartis Foundation (N.A.)
- Stichting Nederlands Oogheelkundig Onderzoek (N.A.)
- Rotterdamse Stichting Blindenbelangen (N.A.)
- Leids Universitair Medisch Centrum (MD/PhD-programme grant)
- European Commission Horizon 2020 UM Cure (667787)
This publication has 34 references indexed in Scilit:
- Different Subsets of Tumor-Infiltrating Lymphocytes Correlate with Macrophage Influx and Monosomy 3 in Uveal MelanomaInvestigative Ophthalmology & Visual Science, 2012
- Estimating prognosis for survival after treatment of choroidal melanomaProgress in Retinal and Eye Research, 2011
- Detection of M2-Macrophages in Uveal Melanoma and Relation with SurvivalInvestigative Ophthalmology & Visual Science, 2011
- Frequent Mutation of BAP1 in Metastasizing Uveal MelanomasScience, 2010
- Comparison of Tumor-Associated Vasculatures in Uveal and Cutaneous MelanomasSeminars in Ophthalmology, 2009
- Vascular Endothelial Growth Factor A in Eyes With Uveal MelanomaArchives of Ophthalmology (1950), 2006
- Angiogenic Profile of Uveal MelanomaCurrent Eye Research, 2006
- Association Between Microarray Gene Expression Signature and Extravascular Matrix Patterns in Primary Uveal MelanomasAmerican Journal of Ophthalmology, 2005
- Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic windowBritish Journal of Ophthalmology, 2002
- Vasculogenic Mimicry and Tumor AngiogenesisThe American Journal of Pathology, 2000